The Federal Trade Commission gave its approval Friday to the biotech

Amgen's

(AMGN) - Get Report

acquisition of

Immunex

(IMNX)

.

The agency's approval removes the sole hurdle to the $11 billion purchase.

An Amgen spokeswoman said the deal would close "soon," but could give no more specifics than that.